🇺🇸 FDA
Pipeline program

Cinacalcet HCl

KKCN201601

Approved small_molecule completed

Quick answer

Cinacalcet HCl for Hyperparathyroidism; Secondary, Renal is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Hyperparathyroidism; Secondary, Renal
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials